每经记者｜温梦华 每经编辑｜叶峰 不过，公司也表示，目前处于预重整阶段，预重整为法院正式受理重整前的程序，公司是否能进入重整 程序尚存在不确定性。即使法院正式受理重整申请，后续仍然存在因重整失败而被宣告破产并被实施破 产清算的风险。如果公司因重整失败而被宣告破产，根据相关规定，公司股票将面临被终止上市的风 险。 《每日经济新闻·将进酒》记者注意到，自2023年7月，拉萨中院决定对连连亏损、资不抵债的ST西发启 动预重整以来，目前ST西发收到法院的延期决定书已多达20余次；并多次发布公司股票可能被终止上 市的风险提示公告。 近几年来，ST西发的业绩承压明显。数据显示，2021年～2024年，ST西发的营收分别为3.93亿元、2.77 亿元、3.37亿元、4.21亿元；归属于上市公司股东的净利润则分别为-0.16亿元、-0.79亿元、-0.26亿元、 0.26亿元。根据7月12日公司发布的业绩预告，2025年上半年净利润预计在1900万元~2850万元。 8月27日，ST西发再次发布预重整延期的公告。 公告称，公司于2025年8月26日收到拉萨中院决定书（2023）藏01破申4号，内容显示，法院认为，临时 管理人 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：000793 证券简称：ST华闻 公告编号：2025-032 一、重要提示 本半年度报告摘要来自半年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投 资者应当到证监会指定媒体仔细阅读半年度报告全文。 所有董事均已出席了审议本报告的董事会会议。 非标准审计意见提示 □适用 √不适用 董事会审议的报告期利润分配预案或公积金转增股本预案 □适用 √不适用 公司计划不派发现金红利，不送红股，不以公积金转增股本。 董事会决议通过的本报告期优先股利润分配预案 □适用 √不适用 公司是否需追溯调整或重述以前年度会计数据 □是 √否 ■ 3、公司股东数量及持股情况 单位：股 ■■ 持股5%以上股东、前10名股东及前10名无限售流通股股东参与转融通业务出借股份情况 □适用 √不适用 前10名股东及前10名无限售流通股股东因转融通出借/归还原因导致较上期发生变化 □适用 √不适用 □适用 √不适用 公司报告期实际控制人未发生变更。 5、公司优先股股东总数及前10名优先股股东持股情况表 □适用 √不适用 公司报告期无优先股股东持股情况。 6、在半年度报告 ...

证券代码：603377 证券简称：ST 东时 公告编号：临 2025-154 警示的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ? 东方时尚驾驶学校股份有限公司（以下简称"公司"）此前因被控股股 东东方时尚投资有限公司（以下简称"东方时尚投资"）及其关联人非经营性占 用资金，余额达到最近一期经审计净资产绝对值 5%以上，且金额超过 1,000 万 元，未能在 1 个月内完成清偿或整改被叠加实施其他风险警示。现上述其他风险 警示情形已完全消除，公司已向上海证券交易所申请撤销对公司股票实施的相应 其他风险警示情形。目前，上述申请已经获得上海证券交易所审核批准。 ? 截至本公告披露日，关于公司前期被实施其他风险警示的情形尚未全部 消除。本次公司股票被撤销部分其他风险警示，但仍存在其他被实施风险警示的 情形。公司股票简称、股票交易的日涨跌幅限制不会发生变化。 ? 截至本公告披露日，公司尚处于预重整阶段，并未收到法院关于进入重 整程序的相关法律文书，公司后续能否进入正式重整程序存在不确定性。根据《上 海证券交易 ...

Group 1 - The company experienced a significant stock price fluctuation, with a cumulative deviation of 35.11% over two consecutive trading days on August 18 and 19, 2025, indicating abnormal trading activity [1] - The company's board of directors conducted inquiries with major stakeholders, including the controlling shareholder and senior management, confirming no undisclosed significant information affecting stock trading [1][2] - The company has not disclosed any major matters related to its pre-restructuring process that have not been previously reported, ensuring compliance with relevant regulations [2][3] Group 2 - The company is currently undergoing a pre-restructuring process, which is a preliminary step before formal restructuring, and the outcome remains uncertain [3] - If the restructuring is successful, it could improve the company's financial structure and sustainability; however, failure could lead to bankruptcy and delisting risks [3]

Core Viewpoint - ST Xiangxue (300147) has received an administrative penalty decision from the China Securities Regulatory Commission (CSRC) due to information disclosure violations, with some penalties being reduced compared to the prior notice [1] Regulatory Actions - The administrative penalty decision no longer imposes a 5-year market ban on the actual controller Wang Yonghui and removes the warning and 500,000 yuan fine against the former independent director Hao Shiming, while other penalties remain consistent with the prior notice [1] Corporate Restructuring - The Guangzhou Intermediate People's Court has agreed to extend the company's pre-restructuring period until October 11, 2025, during which the company will actively cooperate with the temporary administrator and the court [1] - The company has publicly appointed auditing, evaluation, and financial advisory intermediaries, with the auditing and evaluation work progressing smoothly [1] Business Operations - The company emphasizes the clinical value and market potential of TAEST16001 and is fully advancing the preparatory work for confirmatory clinical trials, with updates to be disclosed according to clinical developments and information disclosure rules [1]

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 是否需要提交股东会审议：是 ● 日常关联交易对上市公司的影响：本次日常关联交易遵循公平、公正的 原则，按照市场化原则公允定价，不存在损害公司及中小股东利益的情况，不 会对宁夏中科生物科技股份有限公司（以下简称：宁科生物或公司）的独立性 构成影响，不会对关联人形成依赖或者被其控制。 一、日常关联交易基本情况 （一）新增关联关系及日常关联交易概述 宁夏回族自治区石嘴山市中级人民法院于2024年5月30日作出（2024）宁02 破申2号《决定书》、（2024）宁02破申1号《决定书》，决定对宁科生物及其控股 子公司宁夏中科生物新材料有限公司（以下简称：中科新材）启动预重整，并指 定惠农区人民政府成立的清算组担任临时管理人，负责组织预重整期间各项工作。 招募和遴选重整投资人延期暨重整及预重整事项的进展公告》《关于重整及预重 整事项的进展公告》（公告编号：临2024-101、临2024-185），共有2家产业投资 人在临时管理人要求的期限内提交《重整投资方案》，确定意向 ...

Core Viewpoint - *ST Lingda is facing significant financial and operational challenges, including a lack of actual control, ongoing litigation, and a slow restructuring process, which may lead to bankruptcy if unresolved [1][5][6]. Financial Performance - In 2024, the company reported revenue of 61.15 million yuan, a year-on-year decline of 92.71% [3]. - The net profit attributable to shareholders was -950 million yuan, a decrease of 262.42% year-on-year [3]. Restructuring and Legal Issues - The company and its legal representative, Wang Mingsheng, are under consumption restrictions due to a financing lease dispute with Haier Financing Leasing Co., Ltd., involving approximately 11.69 million yuan [2]. - The pre-restructuring process has been ongoing for over a year, with the company lacking an actual controlling shareholder after the original shareholder's equity was transferred to settle debts [1][6]. - The company has multiple ongoing lawsuits and has been under investigation by the China Securities Regulatory Commission for information disclosure violations [1][2]. Operational Challenges - The subsidiary, Jinzai Jiayue, has faced operational difficulties, including cash flow issues and a halt in production since March 14, 2024, due to funding challenges [4]. - The company announced the termination of the second phase of the TOPCon battery production project on March 31, 2025, due to ongoing financial strain [4]. - A second subsidiary, Golmud Shenguang New Energy Co., Ltd., experienced a temporary shutdown of its photovoltaic power station project due to safety issues [4]. Management Background - Wang Mingsheng has extensive experience in the renewable energy sector, having held various leadership positions in multiple companies prior to his current role at *ST Lingda [3].

Core Viewpoint - The company, Oriental Fashion Driving School Co., Ltd., has failed to rectify fund occupation issues by the deadline set by the Shanghai Stock Exchange, leading to the suspension of its stock and convertible bonds starting June 20, 2025, for a period not exceeding two months [2][3]. Group 1: Company Status and Actions - As of the announcement date, the company has not recovered any of the approximately 387 million yuan occupied by its controlling shareholder and related parties [4]. - The company is currently in a pre-restructuring phase and has not received any legal documents regarding entering a formal restructuring process, creating uncertainty about its future [2][8]. - The company has initiated legal proceedings against Beijing Tonglong Automobile Sales Co., Ltd. for non-compliance with a court mediation agreement, seeking to enforce payment obligations [4]. Group 2: Suspension and Resumption Conditions - The company's stock and convertible bonds will remain suspended until it completes the required rectification during the suspension period; failure to do so will lead to delisting risk warnings [6][7]. - If the company does not complete the necessary rectification within the suspension period, the Shanghai Stock Exchange will implement delisting risk warnings, and if unresolved within an additional two months, it may terminate the listing of the company's stock and convertible bonds [6][7]. Group 3: Regulatory Actions and Compliance - The company received a corrective action order from the Beijing Securities Regulatory Bureau due to suspected violations of information disclosure regulations [3]. - The company is cooperating with the China Securities Regulatory Commission regarding an investigation into its information disclosure practices [6].

Group 1 - The company *ST Huicheng has received a notice from creditor Chongqing Lvfa Asset Management Co., Ltd. regarding its inability to repay due debts and lack of repayment capacity, leading to a pre-restructuring application submitted to the court [1] - As of the notice date, the company owes a total of 227 million yuan to Lvfa Asset, which includes 190 million yuan in principal and 37.44 million yuan in interest [1] - The application for pre-restructuring is uncertain as the company has not yet received any court documents regarding the acceptance of the application [1] Group 2 - The company's stock will be subject to delisting risk warning on April 30, 2025, due to negative net assets and net profit, with expected losses of 26 million to 40 million yuan for the first half of 2025 [2] - The company has improved its performance due to a cross-industry acquisition in the biopharmaceutical sector and has implemented cost control measures to enhance operational efficiency [2] - The company plans to continue focusing on its strategic goals and market expansion while enhancing its operational management to improve profitability [2] Group 3 - If the court accepts the restructuring application, the company will appoint auxiliary institutions and continue normal operations during the pre-restructuring period [3] - The company will engage in various activities such as debt registration, financial audits, and asset evaluations during the pre-restructuring phase [3] - Successful execution of the restructuring plan could mitigate debt risks and optimize the company's financial structure, while failure to do so may lead to bankruptcy and delisting [3]

Group 1 - The core point of the news is that Huanwen Media Investment Group Co., Ltd. has received a pre-restructuring decision from Haikou Intermediate People's Court, which appointed a temporary management team to oversee the company's operations during this period [1][2]. - The temporary management team has issued a notice for creditors to declare their claims by December 1, 2024, through an online system [1][2]. - A second temporary creditors' meeting is scheduled for August 18, 2025, to discuss the financing proposal during the pre-restructuring period [2]. Group 2 - The pre-restructuring decision does not guarantee that the court will formally accept the company's restructuring application, leaving uncertainty regarding the company's future [3]. - If the court accepts the restructuring application, the company's stock may face delisting risk as per the Shenzhen Stock Exchange regulations [4]. - There is a significant risk that the company could be declared bankrupt if the restructuring fails, which would also lead to the termination of its stock listing [5].